ARISTO — Aristo Bio-Tech and Lifescience Balance Sheet

0.000.00%

Last trade - 00:00

Basic MaterialsHighly SpeculativeMicro CapTurnaround

Annual balance sheet for Aristo Bio-Tech and Lifescience, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2019 March 31st	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	4.38	5.25	1.12	4.16	18.5
Net Total Accounts Receivable
Net Total Receivables	473	519	370	378	498
Total Inventory
Total Other Current Assets
Total Current Assets	807	767	691	625	831
Net Property, Plant And Equipment	93.9	111	123	145	167
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	906	879	814	770	998
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	721	649	560	510	595
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	793	755	680	622	697
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	113	123	134	148	302
Total Liabilities & Shareholders' Equity	906	879	814	770	998
Total Common Shares Outstanding